What actually happens in your first 30 days on Mounjaro?

Why does treatment start at such a low dose for a whole month?

If you've read about Mounjaro's clinical trial results (average weight loss of around 20% over 72 weeks at the highest dose, reported in the SURMOUNT-1 study published in the New England Journal of Medicine) it's natural to wonder why the first month involves such a cautious starting point. The answer is nausea. Tirzepatide slows the rate at which your stomach empties food into the small intestine, and that mechanism is exactly what blunts appetite. But starting at a full therapeutic dose would, for most people, produce significant gut discomfort from day one.

The 2.5 mg four-week period exists to give your digestive system time to adapt. Most people find that any nausea peaks in the first week or two and then settles. Appetite suppression is often noticeable even at this starter level, which can feel surprising given that the clinical results data comes from much higher doses.

After 30 days, your prescriber reviews how you've tolerated the starting dose before deciding whether to move to 5 mg, and what happens with Mounjaro after 30 days is covered in detail if you want to know what that review typically involves. That step-up follows a structured schedule described in the NHS tirzepatide medicines page and in the full prescribing information, the timing is a clinical decision, not something to rush.

What side effects are common in the first 30 days of Mounjaro?

Gastrointestinal effects are by far the most frequently reported in early treatment. Nausea tops the list, followed by constipation, indigestion, reflux, and occasional vomiting. Some people also notice fatigue, mild headaches, or dizziness, especially in the first week. Injection-site reactions (a little redness or soreness at the spot) are also possible.

The good news is that these effects tend to front-load. The first week after each dose increase is usually the worst of it, and many people find month one the most uncomfortable phase of the entire treatment course precisely because the body hasn't yet adapted to the mechanism. By the time the dose moves up at the end of the month, the baseline experience is often already better than week one.

Rotating your injection site between the abdomen, thigh, and upper arm helps with localised irritation. Beyond that, the practical habits that help most (staying hydrated, eating smaller meals, avoiding high-fat foods during the adjustment period) are worth discussing with your prescriber or pharmacist. If you have concerns about specific symptoms at any point, the nume support team is available seven days a week.

One thing worth knowing: severe, persistent stomach pain that radiates to the back is not a typical side effect and needs prompt medical attention, it can signal pancreatitis, which the MHRA flagged in a January 2026 Drug Safety Update as a known, though infrequent, serious risk with GLP-1 medicines.

What should you actually check during month one?

There is one practical check that takes under a minute and is worth doing before each weekly injection: look at the pen's liquid through the window. The solution should be clear and colourless. If it looks cloudy, contains particles, or has changed colour, do not use it. This is straightforward to do while the pen is still in the fridge, and it takes seconds. It is the kind of habit that sounds obvious but is easy to skip when you're rushing.

On storage: the pen should be kept refrigerated at 2–8°C. Once you've started using a KwikPen, there is a room-temperature window during which it remains usable, but the exact duration is specified in the Patient Information Leaflet that comes with your pen, and that is the definitive source. Whether the pen is still usable beyond the 30-day mark is a question that depends on storage conditions, and the leaflet gives you the precise answer for your pen format.

Keeping a simple note on your phone of the date you opened the pen is enough. You can also photograph the pen's label when you start using it, handy if the print fades or you're travelling.

What happens after the first 30 days?

Month one ends with a clinical review. At nume, a GPhC-registered prescriber personally reassesses your case before any repeat order goes ahead, this is not automated. If 2.5 mg has been well tolerated, the next step is typically 5 mg for another four weeks. The titration continues, guided by how you're responding and what your prescriber judges appropriate, up through the available UK strengths.

It is worth being realistic: significant weight change in the first 30 days is unlikely for most people. The starter dose was not designed to produce it. Weight loss typically becomes more pronounced as the dose increases over subsequent months, alongside a reduced-calorie diet and more activity, which is the licensed context for this treatment. If you're wondering whether you can continue using Mounjaro after the first 30 days, the short answer is yes, provided your prescriber is satisfied with how you've tolerated the starting dose.

For a fuller picture of the treatment pathway and what private prescribing involves, our Mounjaro overview covers eligibility, how the consultation works, and the cost context. If you'd like to understand how Mounjaro is priced privately, that page explains what a legitimate private prescription includes. And if you're ready to find out whether you're a suitable candidate, speaking to our prescribers is a good starting point, the consultation is free and reviewed the same day by a real clinician.